Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis.
CD25/CD134
Flow cytometry
QFT-Plus
Tuberculosis
Journal
Medical microbiology and immunology
ISSN: 1432-1831
Titre abrégé: Med Microbiol Immunol
Pays: Germany
ID NLM: 0314524
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
16
07
2018
accepted:
30
12
2018
pubmed:
10
1
2019
medline:
23
4
2019
entrez:
10
1
2019
Statut:
ppublish
Résumé
The new QuantiFERON-TB Gold Plus employs modified peptides optimized to elicit an IFNγ response from CD8
Identifiants
pubmed: 30623240
doi: 10.1007/s00430-018-00576-4
pii: 10.1007/s00430-018-00576-4
doi:
Substances chimiques
Antigens, Bacterial
0
IL2RA protein, human
0
Interleukin-2 Receptor alpha Subunit
0
Receptors, OX40
0
TNFRSF4 protein, human
0
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
171-183Références
J Infect Dis. 1999 Jul;180(1):225-8
pubmed: 10353886
Annu Rev Immunol. 1999;17:221-53
pubmed: 10358758
Lancet. 2000 Sep 23;356(9235):1099-104
pubmed: 11009160
J Immunol. 2001 Nov 1;167(9):5217-25
pubmed: 11673535
J Immunol. 2001 Dec 15;167(12):6991-7000
pubmed: 11739519
Am J Respir Crit Care Med. 2003 Dec 1;168(11):1346-52
pubmed: 12969871
Nat Rev Immunol. 2003 Aug;3(8):609-20
pubmed: 12974476
Eur J Immunol. 2003 Dec;33(12):3293-302
pubmed: 14635037
Am J Respir Crit Care Med. 2005 Sep 1;172(5):631-5
pubmed: 15961696
J Clin Microbiol. 2005 Nov;43(11):5779-81
pubmed: 16272518
Clin Exp Immunol. 2006 Apr;144(1):25-34
pubmed: 16542361
J Immunol. 2006 Aug 1;177(3):1780-5
pubmed: 16849488
Clin Immunol. 2007 Apr;123(1):50-9
pubmed: 17234458
Am J Respir Crit Care Med. 2009 Oct 1;180(7):666-73
pubmed: 19590020
J Immunol. 2009 Aug 15;183(4):2827-36
pubmed: 19635903
J Immunol. 2011 Sep 1;187(5):2222-32
pubmed: 21775682
Am J Respir Crit Care Med. 2012 Jan 15;185(2):206-12
pubmed: 22071329
Tuberculosis (Edinb). 2012 Jul;92(4):321-7
pubmed: 22542644
Am J Respir Crit Care Med. 2013 Jan 15;187(2):206-11
pubmed: 23103734
Methods. 2013 May 15;61(1):52-62
pubmed: 23296020
J Immunol. 2013 Feb 15;190(4):1659-71
pubmed: 23319735
Eur J Immunol. 2013 Jun;43(6):1568-77
pubmed: 23456989
PLoS One. 2013 Dec 04;8(12):e81564
pubmed: 24324704
Tuberculosis (Edinb). 2014 Sep;94(5):494-501
pubmed: 25095750
Clin Infect Dis. 2015 Feb 1;60(3):432-7
pubmed: 25362202
Am J Respir Crit Care Med. 2015 Sep 1;192(5):605-17
pubmed: 26030344
Int J Mycobacteriol. 2013 Mar;2(1):58-69
pubmed: 26785791
Surg Infect (Larchmt). 2016 Aug;17(4):394-401
pubmed: 27058682
Clin Microbiol Infect. 2016 Aug;22(8):701-3
pubmed: 27184875
Eur Respir J. 2016 Nov;48(5):1411-1419
pubmed: 27390280
J Infect. 2016 Dec;73(6):588-597
pubmed: 27717779
J Clin Microbiol. 2017 Jun;55(6):1650-1657
pubmed: 28298455
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):690-696
pubmed: 28482964
Tuberculosis (Edinb). 2017 Sep;106:38-43
pubmed: 28802403
Clin Med Insights Case Rep. 2017 Aug 24;10:1179547617724776
pubmed: 28890660
Future Microbiol. 2017 Oct;12:1201-1218
pubmed: 28972418
J Infect Chemother. 2018 Mar;24(3):188-192
pubmed: 29108749
J Clin Microbiol. 2018 Jun 25;56(7):
pubmed: 29743310
Sci Rep. 2018 May 18;8(1):7881
pubmed: 29777119
J Clin Microbiol. 2019 Jan 2;57(1):
pubmed: 30355762